Summary
Introduction
Gastrointestinal infection with Shiga toxin (Stx)-producing E. coli (STEC) strains causes diarrhea and hemorrhagic colitis and, in addition, it is the leading cause of hemolytic uremic syndrome (HUS) (Richardson et al., 1988) . HUS is characterized by a triad of hemolytic anemia, thrombocytopenia, and acute renal failure (Gianantonio et al., 1964; Repetto, 1997) .
HUS is most commonly seen in young children but it is occasionally present in adults (Scully et al., 1995; Repetto, 1997; Frank et al., 2011) , including post-partum women.
The most postpartum cases had preceeded upper respiratory or gastrointestinal symptoms (Strauss et al., 1976; Steele et al., 1984) and at least in one case, HUS was detected after a preterm delivery at 32 weeks (Steele et al., 1984) . However, to our knowledge, an increased risk of preterm delivery linked to STEC infection has not yet been evaluated.
HUS is a systemic complication attributed to the expression of Stx (Karmali et al., 1983) . Two types of Stx may be produced by STEC strains: Stx1 and/or Stx2 with their variants (Paton and Paton, 1998) . In Argentina, STEC strain O157:H7 producing only Stx2 is highly prevalent (Rivas et al., 2006) . Stx is an AB5 holotoxin possessing a single A subunit in noncovalent association with five B subunits (Fraser et al., 1994) . The B subunits form a pentameric ring and mediate toxin binding to the glycolipid receptor globotriaosylceramide (Gb3) expressed in vascular endothelial cells, podocytes, mesangial cells, and proximal tubule epithelial cells of the kidney (Lingwood et al., 1987; Lingwood, 1996) . The A-subunit is an N-glycosidase, which removes an adenine of the 28S ribosomal RNA resulting in cell death (Endo et al., 1988) .
We have previously reported that intraperitoneal (i.p.) administration of Stx2 in the late stage of pregnancy produces preterm delivery of dead fetuses (Burdet et al., 2009) 
(specific activity 150 Ci/mmol), and [5, 6, 8, 9, 11, 12, 14, 
Animals
To obtain timed pregnant females, male and virgin female Sprague-Dawley rats between 250 and 300 g of body weight (bwt) were acquired from the animal facility of the School of Veterinary, University of Buenos Aires. Mating was performed placing the female rats in the cages of the male rats from the same strain for several days. Day 1 of gestation was determined when sperm was observed in the vaginal smear. The animals received food and water ad libitum and were housed under controlled conditions of light (12-h light, 1-h dark) and temperature (23-25°C). This study was carried out in strict 
Experimental Protocols
Pregnant rats on day 15 of gestation (gd) were randomly divided into groups of at least three rats each. The Stx2 injury was induced as previously described (Burdet et al., 2009 ). Briefly, Stx2-treated rats were injected (i.p.) with 0.5 ml of culture supernatant from recombinant E. coli containing 0.7 ng Stx2 and 50 pg LPS/g bwt. Control rats were inoculated with 0.5 ml of culture supernatant containing only LPS (50 pg LPS/g bwt). In separate experiments, control and Stx2-treated rats were injected (i.p.) with AG (100 µg/g bwt) 24 h before and 4 h after toxins injection; Melo (2 µg/g bwt) simultaneously with the toxins and 12, 24 or 36 h later; ETA (100 µg/g bwt) 6 h before toxins; a combination of AG and Melo; or AG and ETA according the protocol previously described for each one. Rats from the different experimental groups were observed daily to evaluate delivery time and fetal status. Some of them were anesthetized and killed by cervical dislocation at different times after treatment. Placenta and decidua tissues were removed to evaluate PGs synthesis, NO synthase (NOS) activity, COX-1 and COX-2 protein expression. Serum and amniotic fluid were obtained to measure TNF-α production.
Determination of Prostaglandins
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© 2012 The Authors British Journal of Pharmacology © 2012 The British Pharmacological Society Placenta and decidua were used to measures PGE 2 and PGF 2α levels as previously detailed (Ribeiro et al., 2005) . Firstly, tissues were incubated for 1 h in Krebs-Ringer bicarbonate solution under a 5%-CO2 atmosphere at 37°C. Afterwards, medium was acidified and PGs were extracted twice with ethyl acetate. 
Western Blot Analysis
Tissues were processed according to the method explained before (Burdet et al., 2010) .
In short, placental and decidual tissues were fragmented and homogenized on ice in an appropriated buffer with protease inhibitors. Homogenates were pre-centrifuged at 2,500 g for 10 min at 4º C and the collected supernatants were additionally centrifuged at 7,800 g for 10 min at 8º C. The supernatants were collected and stored at -70º C until western blotting was performed. Protein concentration was determined with the BCA Protein Assay Kit. One hundred micrograms of protein were loaded in each line.
Samples were separated on 10 % (w/v) sodium dodecyl sulphate-polyacrylamide gel by electrophoresis and transferred to a PVDF membrane. The blots were incubated 48 h at 4ºC with anti-COX-1 or anti-COX-2 rabbit polyclonal antibody diluted 1:250 in PBS. The membranes were then incubated for 1 h at room temperature with horseradish peroxidase-conjugated goat anti-rabbit Ig G antibody (1:3000). Proteins were detected through ECL detection system. To determine the uniformity of loading, protein blots In order to determine whether the alterations in the PGs levels detected in placenta and decidua from Stx2-treated rats may be in part responsible for preterm delivery, Melo, a selective inhibitor of COX-2, was used. (Burdet et al., 2010) . Instead, co-administration of AG and Melo delayed preterm delivery around 2 days in 50% of the rats, 3 days in 17 % of the rats and 4 days in 33 % of the rats but did not prevent the preterm delivery of dead fetuses (Table 1 , row 8). These results suggest that both NO and PGs are involved in the Stx2 action on pregnant rats, although their blockade was not enough to reverse the Stx2-induced preterm delivery.
Stx2 induces deregulation of serum TNF-α production
TNF-α is one of the main cytokines that mediates the inflammatory response to Stx2 and its deregulation, either systemic or locally, could be contributing to the changes observed during the development of pregnancy. To test this hypothesis, we determined the TNF-α levels in serum and amniotic fluid of Stx2-treated rats as well as its toxicity on TNF-sensitive cell line L929.
An increase in TNF-α protein level in serum of Stx2-treated rats was maximal at 2 h after Stx2 injection, after which levels returned to normal at 6 h and 12 h ( Figure 3A) . The pretreatment with ETA was able to prevent the increase of TNF-α production in serum samples induced by Stx2 (Figure 4) . ETA also prevented the significant increase in placental PGE 2 (p < 0.001, n = 18) and decidual PGF 2α (p < 0.001, n = 18) levels caused by Stx2 ( Figure 5A and B) . In contrast, no significant difference in placental NOS activity was found in rats treated with ETA + Stx2 compared with Stx2 alone. In both cases, a significant increase in NOS activity in placental tissues (p< 0.01, n = 6) was observed compared with the Control (Figure 6 ).
ETA and AG prevent the preterm delivery induced by Stx2
To determine whether the increase in TNF-α production and NOS activity triggers the Stx2 induced preterm delivery, we evaluated the action of ETA on the delivery time and fetal status of Stx2-treated rats. Administration of ETA 6 h before Stx2 injection prevented the preterm delivery by roughly 30% compared with their Controls (Table 1 row 10 vs 9). Furthermore, we evaluated the combined action of AG and ETA in Stx2-treated rats compared with Control rats. For the first time, we observed that the treatment with both inhibitors, AG plus ETA, significantly (p< 0.005, n = 10) prevented Stx2-induced preterm delivery by 70 % of the cases (Table 1 , row 12). The pups of these rats were born alive and had normal development compared with their Controls (Table 1 , row 11). These results suggest that the overproduction of TNF-α and NO is the major responsible of the preterm delivery of dead fetuses induced by Stx2.
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Discussion
In this study, a significant increase in placental PGE 2 and decidual PGF 2α was found in Stx treated rats. Additionally, in both tissues COX-2 protein expression was stimulated by Stx2, although Melo, a specific inhibitor of COX-2, was unable to prevent placental toxicity and fetal mortality. Here, we found that production of PGs and expression of COX-2 protein were modulated by NOS activity in Stx2-treated rats. Thus, it is reasonable to infer that NO could elicit different effects on the progression of pregnancy, some directly related with its overproduction and others related with the regulation of PG production (Aisemberg et al., 2007) . We reported before that AG prevented placental damages in Stx2-treated rats but did not prevent preterm delivery (Burdet et al., 2010) . Here, the administration of AG together with Melo delayed preterm delivery but did not prevent it, which indicates that other factors are involved in the Stx2-induced preterm delivery. It is well known that Stx may act in concert with LPS to elicit cellular dysfunction (Louise and Obrig, 1992) . Stx is able to bind to Gb3 receptors expressed on the membrane of monocytes/macrophages and leads to cellular activation and secretion of cytokines such as TNF-α, IL-1β and IL-8 that increase the endothelial susceptibility to Stx (Ibarra and Palermo, 2010) . Many studies conducted in human and experimental animals have established that a correct balance of cytokines at the maternal-fetal interface is an essential requirement for proper placental development and therefore reproductive success (Peltier, 2003; Gravett et al., 2007) . In pregnant rats, administration of TNF-α produced placental injury and fetal death similar to the effects observed after LPS exposure (Silen et al., 1989) . In this study, we showed that a significant increase in serum TNF-α observed 2 h after Stx2 treatment may be responsible for preterm delivery. (Grigsby et al., 2003; Renaud et al., 2011) . TNF-α in amniotic fluid was not detected suggesting that maternal more than fetal TNF-α exert its detrimental effects on pregnancy. Administration of ETA completely prevented the increase in serum TNF-α level caused by Stx2 as previously demonstrated in astrocytes treated with LPS and Stx1 (Landoni et al., 2010) . Moreover, ETA prevented by 30% the preterm delivery caused by Stx2 and, although this is not significant, shows a tendency to the Stx2 effect prevention. Our results indicate that TNF-α may play a causal role in Stx2 pregnancy loss consistent with previous studies reported in human and animal models (Silver et al., 1994; Raghupathy et al., 2000) .
ETA also inhibited the induction of placental PGE 2 and decidual PGF 2α synthesis in Stx2-treated rats even in the presence of AG. These findings indicate that TNF-α stimulates PG production independent of NO production as it is described in the literature (Romero et al., 1988; Sato et al., 2003) . ETA did not inhibit the increase of placental NOS activity caused by Stx2. Thus, it is reasonable to infer that Stx2-induced increase in NO production is not mediated by TNF-α. We assayed the combined action of AG and ETA on fetal status and delivery time in Stx2-treated rats. Co-administration of AG and ETA significantly prevented the preterm delivery caused by Stx2 by approximately 70% of the cases. The pups of these rats were similar in size and weight to those observed in the controls. These results indicate that the preterm delivery of dead fetuses induced by Stx2 is triggered by TNF-α and mediated by an increase in NOS production. Both placental PGE 2 and decidual PGF 2α increase secondarily to the increase in TNF-α and output of iNOS and contribute to the mechanisms that lead to the preterm delivery. In conclusion, the model presented in this study is relevant because it shows that Stx2 increases TNF-α production, which renders the feto-maternal unit more susceptible to Stx2 through the stimulation of local PGs synthesis, which in turn may activate uterine contractions and cervical dilation. This proinflammatory environment could promote the contraction of the uterus and the expulsion of the fetuses. Additionally, Stx2 induces the overproduction of NO as a consequence of an increase in the levels of iNOS protein in placental tissues, which plays an important role in placental toxicity and fetal mortality.
It is important to notice the fact that the administration of AG and ETA partially prevented preterm delivery of dead fetuses induced by Stx2. This suggests that they could be used in the future as therapeutic agents in this pathological consequence of HUS. 
